|
Home
Search
Study Topics
Glossary
|
![]() |
![]() |
|
![]() |
|
![]() |
|
![]() |
![]() |
![]() |
|
![]() |
![]() |
||||||||||||||||||||||||||||||||||||
| Sponsor: | McGill University Health Center |
|---|---|
| Information provided by: | McGill University Health Center |
| ClinicalTrials.gov Identifier: | NCT00737984 |
Purpose
Endometrial sampling improves the pregnancy rates in superovulation-IUI cycles
| Condition | Intervention |
|---|---|
|
Infertility Clinical Pregnancy Rate |
Procedure: Endometrial sampling |
| Study Type: | Interventional |
| Study Design: | Treatment, Randomized, Open Label, Single Group Assignment |
| Official Title: | Improving the Pregnancy Rate With Endometrial Sampling Before Intrauterine Insemination |
| Estimated Enrollment: | 162 |
| Study Start Date: | August 2008 |
| Estimated Study Completion Date: | August 2010 |
| Estimated Primary Completion Date: | June 2010 (Final data collection date for primary outcome measure) |
| Arms | Assigned Interventions |
|---|---|
|
1: No Intervention
Group 1 patients will receive standard superovulation-IUI treatment without endometrial sampling
|
|
|
2: Active Comparator
Group 2 patients will receive standard superovulation-IUI treatment with endometrial sampling performed in the preceding cycle. It will be done in the follicular phase not later than day 10 of the cycle
|
Procedure: Endometrial sampling
Endometrial sampling performed in the preceding cycle. It will be done in the follicular phase not later than day 10 of the cycle
|
Endometrial sampling is performed using the standard technique in the outpatient department. Similarly, superovulation with gonadotrophins will be performed according to our standard practice.Endometrial sampling will be done in the follicular phase not later than day 10 of the cycle. Endometrial sampling will be performed using Pipelle sampling catheter. The Pipelle is inserted gently through the cervical canal into the uterine cavity and advanced slowly till just resistance felt by the operator. Then, the piston is withdrawn to create negative suction and gentle movement of Pipelle up and down in the uterine cavity is performed while it is against the uterine wall. The Pipelle catheter is withdrawn gently and any obtained specimen will be sent for histopathological examination.
Eligibility| Genders Eligible for Study: | Female |
| Accepts Healthy Volunteers: | No |
Inclusion Criteria:
Exclusion Criteria:
Contacts and Locations| Contact: Togas Tulandi, MD, MHCM | togas.tulandi@mcgill.ca |
| Canada, Quebec | |
| McGill University Health Center | Recruiting |
| Montreal, Quebec, Canada, H3A 1A1 | |
| Contact: Togas Tulandi, MD, MHCM togas.tulandi@mcgill.ca | |
| Principal Investigator: Togas Tulandi, MD, MHCM | |
| Sub-Investigator: Mohammed Agdi, MD | |
| Principal Investigator: | Togas Tulandi, MD, MHCM | McGill University Health Center |
More Information
| Responsible Party: | McGill University health center ( Togas Tulandi, MD, MHCM ) |
| Study ID Numbers: | SDR-08-004 |
| Study First Received: | August 18, 2008 |
| Last Updated: | October 14, 2009 |
| ClinicalTrials.gov Identifier: | NCT00737984 History of Changes |
| Health Authority: | Canada: Ethics Review Committee |
|
Infertility Clinical pregnancy rate |
|
Genital Diseases, Female Infertility Genital Diseases, Male |